Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Embolic Protection
Author(s):
Jennifer Franke
,
Horst Sievert
Added:
3 years ago
Article
Author(s):
Sam Dawkins
Added:
1 year ago
ACI BCIS 2023 — Dr Sam Dawkins (The Manor Hospital, UK) joins us to share his insights on cerebral embolic protection from an UK perspective. Dr Dawkins, who is involved with the BHF-Protect study, highlights the importance of data on effectiveness and some of the remaining questions in relation to cerebral embolic protection devices.
Recorded at BCIS ACI 2023, London.
View more
Author(s):
Vijay Kunadian
,
Richard J Jabbour
,
Rajesh Kharbanda
Added:
1 year ago
ACI 2023 — Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) joined by Prof Raj Kharbanda (John Radcliffe Hospital, Oxford, UK), lead researcher of BHF PROTECT-TAVI trial, and Dr Richard J Jabbour (University Hospital Southampton NHS FT, UK) to discuss the use of embolic protection devices in 2023.
This insightful discussion covers various aspects of the topic of embolic…
View more
Author(s):
Martin G Radvany
Added:
3 years ago
Catheter-based vascular interventions continue to evolve as new devices continue to expand the capabilities of interventionalists and improve patient safety. The importance of athero-embolisation during vascular intervention has long been recognised.1 Embolic protection devices (EPDs) were developed to help prevent embolisation during endovascular procedures. The risk of distal embolisation is…
View more
Author(s):
Michael Teitelbaum
,
Rafail Kotronias
,
Luciano A Sposato
,
et al
Added:
3 years ago
Since its introduction in 2002, transcatheter aortic valve implantation (TAVI) has provided an alternative to surgical aortic valve replacement (SAVR) in patients considered inoperable or either at high or intermediate risk for SAVR.1 However, one of the most feared complications of TAVI are cerebrovascular accidents (CVA) including stroke or transient ischaemic attack. Further to this, TAVI…
View more
Author(s):
Eberhard Grube
Added:
3 years ago
The importance of embolisation in atherosclerotic vascular disease has recently undergone a major change in mindset. In the 1990s, it was considered a rare event confined to degenerated and aged saphenous vein grafts (SVGs). Lately, however, embolisation has become a major issue to contend with, not only in SVG but in all carotid artery stenting, in acute myocardial infarction (AMI) and in…
View more
Author(s):
Rajesh Kharbanda
,
Tessel Vossenberg
Added:
10 months ago
In this exclusive interview, Dr Tessel Vossenberg (Medical Center Leeuwarden, Leeuwarden, NL) speaks with Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK),Principal Investigator of the BHF PROTECT TAVI trial.This highly anticipated trial aims to provide groundbreaking insights into the field of Cerebral Embolic Protection (CEP) in TAVI.
In this interview, Dr…
View more
Author(s):
William R Colyer Jr
,
Christopher J Cooper
Added:
3 years ago
Atherosclerotic renal artery stentosis (RAS) is a frequently recognised cause of secondary hypertension and chronic kidney disease.1–4 Revascularisation of RAS with angioplasty and stenting is often performed with the goals of improved blood pressure control and preserving or improving renal function.5 However, renal artery stenting is sometimes associated with acute worsening of renal function.6…
View more
Need for Embolic Protection During Transcatheter Aortic Valve Implantation: An Interventionalist’s…
Author(s):
Herbert G Kroon
,
Nicolas M Van Mieghem
Added:
3 years ago
Article